HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fernando C Fervenza Selected Research

Albumins

10/2023Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy.
8/2014A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy.
12/2012Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases.
5/2007Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fernando C Fervenza Research Topics

Disease

54Proteinuria
05/2024 - 05/2004
45Glomerulonephritis
05/2024 - 05/2004
45Membranous Glomerulonephritis (Membranous Nephropathy)
04/2024 - 05/2004
33Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
05/2024 - 01/2006
25Vasculitis (Vasculitides)
05/2024 - 03/2010
19Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
03/2024 - 04/2010
17Paraproteinemias (Monoclonal Gammopathy)
03/2023 - 02/2009
16Chronic Kidney Failure (Chronic Renal Failure)
05/2024 - 01/2004
15Infections
05/2024 - 01/2005
15Kidney Diseases (Kidney Disease)
05/2024 - 01/2011
15IGA Glomerulonephritis (IGA Nephropathy)
01/2024 - 05/2004
15Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2023 - 05/2004
13Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
05/2024 - 01/2005
12Microscopic Polyangiitis
05/2024 - 11/2006
11Autoimmune Diseases (Autoimmune Disease)
01/2023 - 11/2006
10Inflammation (Inflammations)
12/2023 - 01/2005
9Atypical Hemolytic Uremic Syndrome
01/2023 - 06/2014
8Lupus Nephritis
05/2024 - 04/2012
8Amyloidosis
01/2018 - 05/2007
7Hematuria
12/2023 - 11/2006
7Neoplasms (Cancer)
09/2023 - 07/2012
7Nephrotic Syndrome (Syndrome, Nephrotic)
03/2023 - 08/2014
6Renal Insufficiency (Renal Failure)
01/2024 - 05/2004
6Thrombotic Microangiopathies
01/2023 - 12/2012
6Acute Kidney Injury (Acute Renal Failure)
01/2023 - 05/2004
6Hemorrhage
01/2021 - 02/2005
6Multiple Myeloma
01/2021 - 01/2004
5B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018 - 01/2005
4Fibrosis (Cirrhosis)
09/2023 - 06/2011
4Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
01/2023 - 04/2014
4Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome)
01/2022 - 02/2005
4Interstitial Nephritis (Tubulointerstitial Nephritis)
07/2015 - 01/2005
4Churg-Strauss Syndrome (Allergic Angiitis)
04/2014 - 01/2011
3Rare Diseases (Rare Disease)
04/2024 - 06/2023
3COVID-19
12/2021 - 01/2021
3Fabry Disease (Fabry's Disease)
01/2020 - 11/2004
3Chronic Renal Insufficiency
09/2019 - 01/2016
3Rheumatoid Arthritis
01/2017 - 07/2012
2Undiagnosed Diseases
04/2024 - 06/2023
2Disease Progression
02/2024 - 12/2015
2Leukopenia
09/2023 - 04/2012
2Atrophy
10/2022 - 01/2021
2Nephritis
08/2022 - 04/2016

Drug/Important Bio-Agent (IBA)

45Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
05/2024 - 01/2006
43Rituximab (Mabthera)FDA Link
04/2024 - 01/2006
30Complement System Proteins (Complement)IBA
03/2024 - 05/2011
24CreatinineIBA
09/2023 - 05/2004
23Antigen-Antibody Complex (Immune Complex)IBA
03/2024 - 02/2006
20Proteins (Proteins, Gene)FDA Link
01/2023 - 11/2004
16AntigensIBA
02/2024 - 01/2011
16AntibodiesIBA
10/2023 - 02/2005
16Immunoglobulins (Immunoglobulin)IBA
01/2022 - 05/2008
15Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2024 - 01/2006
12Biomarkers (Surrogate Marker)IBA
12/2023 - 06/2011
8Immunoglobulin A (IgA)IBA
01/2024 - 02/2005
8SteroidsIBA
01/2024 - 08/2011
8Immunoglobulin G (IgG)IBA
12/2023 - 02/2006
8Phospholipase A2 ReceptorsIBA
10/2023 - 03/2012
7Peroxidase (Myeloperoxidase)IBA
05/2024 - 11/2006
7AutoantibodiesIBA
05/2024 - 07/2011
7Dichlorodiphenyldichloroethane (DDD)IBA
03/2024 - 11/2010
6Mycophenolic Acid (Cellcept)FDA LinkGeneric
05/2024 - 03/2010
6Myeloblastin (Proteinase 3)IBA
05/2024 - 01/2019
6Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2024 - 01/2015
6Monoclonal AntibodiesIBA
09/2017 - 09/2011
5Prednisone (Sone)FDA LinkGeneric
05/2024 - 09/2013
5GlucocorticoidsIBA
05/2024 - 07/2010
4AlbuminsIBA
10/2023 - 05/2007
4Adrenal Cortex Hormones (Corticosteroids)IBA
09/2023 - 04/2012
4eculizumabFDA Link
01/2023 - 06/2015
4Complement Factor H (Factor H)IBA
10/2018 - 07/2012
3Immunosuppressive Agents (Immunosuppressants)IBA
05/2024 - 05/2010
3ApolipoproteinsIBA
03/2024 - 06/2013
3Calcineurin InhibitorsIBA
09/2023 - 09/2017
3DNA (Deoxyribonucleic Acid)IBA
01/2023 - 01/2019
3CollagenIBA
01/2023 - 02/2005
3Serum AlbuminIBA
08/2020 - 08/2014
3alpha-Galactosidase (Beano)IBA
01/2020 - 11/2004
3ThrombospondinsIBA
01/2019 - 02/2015
3Alkylating AgentsIBA
01/2018 - 08/2013
3Azathioprine (Imuran)FDA LinkGeneric
01/2017 - 08/2013
3Bortezomib (Velcade)FDA Link
07/2015 - 09/2013
3ElectrolytesIBA
05/2014 - 07/2002
2Hemoglobins (Hemoglobin)IBA
12/2023 - 11/2008
2CryoglobulinsIBA
01/2022 - 01/2018
2Complement C3 (C3 Complement)IBA
01/2022 - 06/2014
2VaccinesIBA
12/2021 - 01/2021
2Peptide Hydrolases (Proteases)FDA Link
11/2021 - 01/2017
2C-Reactive ProteinIBA
11/2021 - 01/2016

Therapy/Procedure

32Therapeutics
05/2024 - 08/2005
11Remission Induction
05/2024 - 01/2006
9Kidney Transplantation
10/2020 - 01/2004
6Lasers (Laser)
11/2020 - 07/2012
6Transplantation
09/2020 - 06/2008
4Plasma Exchange
01/2022 - 01/2016
4Stem Cell Transplantation
03/2012 - 08/2005
3Precision Medicine
06/2023 - 01/2020
3Renal Dialysis (Hemodialysis)
01/2019 - 04/2016
2Genomic Medicine
04/2024 - 06/2023
2Renal Replacement Therapy (Therapies, Renal Replacement)
01/2024 - 10/2020